It is difficult to ascertain if IL-18 is a good indicator of severity of atherosclerosis, but it seems to be a good indicator of its clinical complications among patient suffering from CKD, without diabetes mellitus, and with AMI in the year prior to the enrolment. This evidence concerns the gene IL18 and chronic kidney disease.